1362 related articles for article (PubMed ID: 22374080)
1. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
[TBL] [Abstract][Full Text] [Related]
2. Future development of global regulations of Chinese herbal products.
Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
[TBL] [Abstract][Full Text] [Related]
3. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance of herbal medicine.
Shaw D; Graeme L; Pierre D; Elizabeth W; Kelvin C
J Ethnopharmacol; 2012 Apr; 140(3):513-8. PubMed ID: 22342381
[TBL] [Abstract][Full Text] [Related]
5. [Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].
Zhao J; Ye Z
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2193-8. PubMed ID: 23189716
[TBL] [Abstract][Full Text] [Related]
6. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
Zhang L; Yang XH; Cao LY; Ji S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
[TBL] [Abstract][Full Text] [Related]
7. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
Wang HN; Chen W; Fu Z; Du WM; He J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
[TBL] [Abstract][Full Text] [Related]
8. [Establishment and application of "multi-dimensional structure and process dynamic quality control technology system" in preparation products of traditional Chinese medicine (I)].
Gu JF; Feng L; Zhang MH; Wu C; Jia XB
Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3613-7. PubMed ID: 24494541
[TBL] [Abstract][Full Text] [Related]
9. [Some key issues about scientific research on traditional Chinese medicine].
Xiao X; Xiao P; Wang Y
Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(2):119-23. PubMed ID: 19385166
[TBL] [Abstract][Full Text] [Related]
10. [Significance of re-evaluation and development of Chinese herbal drugs].
Gao Y; Ma Z; Zhang B
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
[TBL] [Abstract][Full Text] [Related]
11. [Safety research in Chinese medicines based on application of data mining].
Tong Y; Yang J; Li C; He W
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance in Traditional Chinese Medicine safety surveillance.
Wang H; Ye X; Gao Q; Wu C; Qian Y; Luo B; Sun Y; He J
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):357-61. PubMed ID: 19253921
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.
Uzuner H; Bauer R; Fan TP; Guo DA; Dias A; El-Nezami H; Efferth T; Williamson EM; Heinrich M; Robinson N; Hylands PJ; Hendry BM; Cheng YC; Xu Q
J Ethnopharmacol; 2012 Apr; 140(3):458-68. PubMed ID: 22387462
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcomes research of traditional Chinese medicine--introduce registry intensive hospital monitoring study protocol of traditiona Chinese medicine injection's safety].
Yang W; Xie YM; Wang YY
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2683-5. PubMed ID: 23285907
[TBL] [Abstract][Full Text] [Related]
15. Toxicological risks of Chinese herbs.
Shaw D
Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
[TBL] [Abstract][Full Text] [Related]
16. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia.
Xie W; Zhao Y; Du L
J Ethnopharmacol; 2012 Mar; 140(2):345-67. PubMed ID: 22306102
[TBL] [Abstract][Full Text] [Related]
17. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
Jiang JJ; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
[TBL] [Abstract][Full Text] [Related]
18. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
Xiang F; Zhang X
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
[TBL] [Abstract][Full Text] [Related]
19. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
Wei X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
[TBL] [Abstract][Full Text] [Related]
20. [Probing into objectivity of adverse drug reaction of traditional Chinese medicine].
Sun YQ; Ma YG; Xing XY; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1381-3. PubMed ID: 17061563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
